Multiplex opsonophagocytosis assay (MOPA): A useful tool for the monitoring of the 7-valent pneumococcal conjugate vaccine

Vaccine

Volumn 22, Issue 29-30, 2004, Pages 4014-4020

  Bogaert, D ^a   Sluijter, M ^a   De Groot, R ^a   Hermans, P W M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Conjugate vaccine; Correlate of protection; Opsonophagocytosis; Streptococcus pneumoniae

Indexed keywords

AGAR; CHLORAMPHENICOL; ERYTHROMYCIN; OPSONIN; PNEUMOCOCCUS VACCINE; RIFAMPICIN; SPECTINOMYCIN; STREPTOMYCIN; TETRACYCLINE; TRIMETHOPRIM;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CELL DIFFERENTIATION; COLONY FORMING UNIT; CORRELATION ANALYSIS; DRUG EFFICACY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOLOGICAL MONITORING; MEASUREMENT; NONHUMAN; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

ANTIBODIES, BACTERIAL; CELLS, CULTURED; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; HL-60 CELLS; HUMANS; IMMUNOLOGIC TECHNIQUES; MENINGOCOCCAL VACCINES; OPSONIN PROTEINS; PHAGOCYTOSIS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE;

EID: 4444375185     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.03.049     Document Type: Article

References (19)

1. Pneumococcal vaccines: WHO position paper. Wkly Epidemiol Rec 1999;74(23):177-84.
2. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(RR-8):1-24.
3. Black S. Efficacy of heptavalent conjugate pneumococcal vaccine in 37000 infants and children: results of the Northern California Kaiser Permanente efficacy trial. Oakland, USA: Kaiser Permanente Vaccine Study Center; 1998.
4. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr. Infect. Dis. J. 19(3):2000;187-195
5. Parkkali T., Vakevainen M., Kayhty H., Ruutu T., Ruutu P. Opsonophagocytic activity against Streptococcus pneumoniae type 19F in allogeneic BMT recipients before and after vaccination with pneumococcal polysaccharide vaccine. Bone Marrow Transplant. 27(2):2001;207-211
6. Rodriguez M.E., Van der Pol W., Van de Winkel J.G. Flow cytometry-based phagocytosis assay for sensitive detection of opsonic activity of pneumococcal capsular polysaccharide antibodies in human sera. J. Immunol. Methods. 252(1-2):2001;33-44
7. Vakevainen M., Jansen W., Saeland E., Jansdottir I., Snippe H., Verheul A., et al. Are the opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable? Clin. Diagn. Lab. Immunol. 8(2):2001;363-369
8. Romero-Steiner S., Libutti D., Pais L.B., Dykes J., Anderson P., et al. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin. Diagn. Lab. Immunol. 4(4):1997;415-422
9. Nahm M.H., Briles D.E., Yu X. Development of a multi-specificity opsonophagocytic killing assay. Vaccine. 18(24):2000;2768-2771
10. Borrow R., Richmond P., Kaczmarski E.B., Iverson A., Martin S.L., Findlow J. Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccine. FEMS Immunol. Med. Microbiol. 28(1):2000;79-85
11. Veenhoven R., Bogaert D., Uiterwaal C., Brouwer C., Kiezebrink H., Bruin J., et al. Effect of pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media. Lancet. 361:2003;2189-2195
12. Bricker A.L., Camilli A. Transformation of a type 4 encapsulated strain of Streptococcus pneumoniae. FEMS Microbiol. Lett. 172(2):1999;131-135
13. Goessens W.H., Lemmens-den Toom N., Hermans P.W., Sluijter M., de Groot R., et al. Evaluation of the Vitek 2 system for susceptibility testing of Streptococcus pneumoniae isolates. Eur. J. Clin. Microbiol. Infect. Dis. 19(8):2000;618-622
14. Kayhty H., Ahman H., Ronnberg P.R., Tillikainen R., Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J. Infect. Dis. 172(5):1995;1273-1278
15. Quataert S.A., Kirch C.S., Wiedl L.J. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clin. Diagn. Lab. Immunol. 2(5):1995;590-597
16. Black S.B., Shinefield H.R., Ling S., Hansen J., Firemans B., Spring D., et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia. Pediatr. Infect. Dis. J. 21(9):2002;810-815
17. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakoski J., Herna E., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 344(6):2001;403-409
18. Jansen W.T., Gootjes J., Zelle M., Madore D.V., Verhoet J., Snippe H., et al. Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies. Clin. Diagn. Lab. Immunol. 5(5):1998;703-710
19. Jansen W.T., Vakevainen-Anttila M., Kayhty H., Nahm M., Bakker N., Verhoef J., et al. Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated with a pneumococcal conjugate vaccine. Clin. Diagn. Lab. Immunol. 8(2):2001;245-250